Anti-Depressants vs Physiotherapy in Management of Fibromyalgia
Primary Purpose
Fibromyalgia
Status
Completed
Phase
Phase 3
Locations
India
Study Type
Interventional
Intervention
Physiotherapy
Amitryptiline
Sponsored by
About this trial
This is an interventional treatment trial for Fibromyalgia
Eligibility Criteria
Inclusion Criteria:
- Patient's between 18-60 yrs, belonging to either sex. With symptoms of chronic muscular pain of at least 12 weeks (that may or may not be consecutive) who fulfill the American College of Rheumatology (ACR) criteria for the diagnosis of Fibromyalgia
Exclusion Criteria:
- Patients of age group more than 60 yrs and below 18 years
- Pregnant or lactating females.
- Patients with a history of trauma.
- Patients with severe co morbid illness which prevents physical activity (for example, cardiovascular problems)
- Patients with the presence of specific medical disorders which require immediate treatment (for example, fractures, infectious diseases),
- Patients with associated neurological abnormality
Sites / Locations
- Mahatma Gandhi Institute of Medical Sciences
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
2
1
Arm Description
anti-depressants
physiotherapy
Outcomes
Primary Outcome Measures
Reduction in FIQ score from the baseline
Secondary Outcome Measures
Reduction in Tender point score
Reduction in Brief psychiatric rating score
Full Information
NCT ID
NCT00704899
First Posted
June 23, 2008
Last Updated
June 25, 2008
Sponsor
Mahatma Gandhi Institute of Medical Sciences
1. Study Identification
Unique Protocol Identification Number
NCT00704899
Brief Title
Anti-Depressants vs Physiotherapy in Management of Fibromyalgia
Official Title
Effect of Anti-Depressants vs Physiotherapy in Management of Fibromyalgia Syndrome: What Predicts a Clinical Benefit?
Study Type
Interventional
2. Study Status
Record Verification Date
June 2008
Overall Recruitment Status
Completed
Study Start Date
March 2006 (undefined)
Primary Completion Date
December 2007 (Actual)
Study Completion Date
April 2008 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Mahatma Gandhi Institute of Medical Sciences
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
To compare the efficacy of physiotherapy and anti-depressants in disability reduction in patients of Fibromyalgia syndrome.
Detailed Description
Research Question:
Does the use of physiotherapy or pharmacotherapy help in improving quality of life in patients of fibromyalgia as judged by fibromyalgia impact questionnaire at a 6 month follow up period?
Study hypothesis:
Physiotherapy is no better than pharmacotherapy in improving the quality of life in patients of fibromyalgia as judged by fibromyalgia impact questionnaire.
Study type- Interventional STUDY DESIGN: open label alternate patient treatment allocation Ethical approval for the trial protocol has been obtained from the institute's ethics committee of Mahatma Gandhi Institute of Medical Sciences, Sevagram.
Subjects and Methods The study will be conducted in Kasturba Hospital and Mahatma Gandhi Institute of Medical Sciences, Sevagram, from 1 march 2006 - 1 dec 2007. Patients will be selected to enter the study, in such a way that every patient presenting with chronic muscular pain will be screened in the study and patients fulfilling inclusion criteria will be recruited in the study.
Study population:
Total of 175 patients will be included in the study.
Methods:
The investigators will screen all patients who are referred to them for inclusion in the study. Written informed consent will be obtained from all participants. The patients included in the study will be administered a standardized questionnaire to record socio-demographic characteristics, symptom characteristics and history of previous visits to a health care provider. The socio-economic score (SES) will be determined using a validated questionnaire.[6] Briefly, the questionnaire consists of following: (1) household profile, (2) material possession profile, (3) educational profile, (4) occupational profile, (5) economic profile (6) possessed land or house cost profile and (7) social profile. Fibromyalgia impact questionnaire (FIQ) will be used to determine a baseline score. [7] For the purpose of the study this questionnaire is translated to local language (Marathi), and back-translated to English to ensure its accuracy. Minor modifications have been done in the questionnaire to make it suitable for our setting (for example: the use of washer or dryer for laundry was modified to washing the laundry by themselves). Assessment of psychiatric co morbidity will be done using the Brief Psychiatric Rating Scale (BPRS), which is an 18 item instrument, each item has a seven severity grades.[8] A score of 32 or more indicates presence of psychopathology.[9]
Interventions:
A trained Physiotherapist will conduct a uniform structured physical training and aerobic session for one group of patients. The patients will be advised to perform the exercises daily twice for at least 10 minutes. There will be a step up pattern of exercise regimen followed with relaxation, stretching and strengthening techniques. The methodology is described in box 1. The second group of patients will receive antidepressant in the form open label amitriptyline 25 mg once daily at bedtime. The dose of the drug may be increased if required. All patients will be also offered pharmacologic treatment with 50 mg tramadol in thrice daily doses and as required. The treatment recommendations are based on standard recommendations on the management of fibromyalgia.[5]
Outcome assessment All patients will be followed up for six months at monthly intervals. At each visit the study investigators will determine the course of the disease and compliance with therapy. The FIQ score will be assessed at the end of 6 monthly visits. Reduction in FIQ score from the baseline will be used as the principle outcome measure.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fibromyalgia
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
175 (Actual)
8. Arms, Groups, and Interventions
Arm Title
2
Arm Type
Experimental
Arm Description
anti-depressants
Arm Title
1
Arm Type
Experimental
Arm Description
physiotherapy
Intervention Type
Procedure
Intervention Name(s)
Physiotherapy
Intervention Description
Structured exercise regimen
Intervention Type
Drug
Intervention Name(s)
Amitryptiline
Intervention Description
Amitryptiline 25mg once daily
Primary Outcome Measure Information:
Title
Reduction in FIQ score from the baseline
Time Frame
Two years
Secondary Outcome Measure Information:
Title
Reduction in Tender point score
Time Frame
Two years
Title
Reduction in Brief psychiatric rating score
Time Frame
Two Years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient's between 18-60 yrs, belonging to either sex. With symptoms of chronic muscular pain of at least 12 weeks (that may or may not be consecutive) who fulfill the American College of Rheumatology (ACR) criteria for the diagnosis of Fibromyalgia
Exclusion Criteria:
Patients of age group more than 60 yrs and below 18 years
Pregnant or lactating females.
Patients with a history of trauma.
Patients with severe co morbid illness which prevents physical activity (for example, cardiovascular problems)
Patients with the presence of specific medical disorders which require immediate treatment (for example, fractures, infectious diseases),
Patients with associated neurological abnormality
Facility Information:
Facility Name
Mahatma Gandhi Institute of Medical Sciences
City
Sevagram
State/Province
Maharashtra
ZIP/Postal Code
442102
Country
India
12. IPD Sharing Statement
Learn more about this trial
Anti-Depressants vs Physiotherapy in Management of Fibromyalgia
We'll reach out to this number within 24 hrs